Mark A. Young

2.6k total citations
86 papers, 1.8k citations indexed

About

Mark A. Young is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Mark A. Young has authored 86 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 13 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Mark A. Young's work include Cardiac electrophysiology and arrhythmias (8 papers), Musculoskeletal Disorders and Rehabilitation (8 papers) and Tendon Structure and Treatment (7 papers). Mark A. Young is often cited by papers focused on Cardiac electrophysiology and arrhythmias (8 papers), Musculoskeletal Disorders and Rehabilitation (8 papers) and Tendon Structure and Treatment (7 papers). Mark A. Young collaborates with scholars based in United States, Australia and United Kingdom. Mark A. Young's co-authors include Jill Cook, Hylton B. Menz, Damien Irving, Z S Kiss, Craig Purdam, H Alfredson, J L Cook, Stephen F. Vatner, Kevin Mullane and R. Douglas Watson and has published in prestigious journals such as JAMA, Blood and Circulation Research.

In The Last Decade

Mark A. Young

81 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Young United States 23 583 481 394 290 241 86 1.8k
Heidi Prather United States 30 467 0.8× 2.5k 5.3× 317 0.8× 171 0.6× 156 0.6× 97 3.3k
J. W. J. Bijlsma Netherlands 27 198 0.3× 708 1.5× 52 0.1× 238 0.8× 81 0.3× 57 2.6k
Antonino Catalano Italy 25 588 1.0× 209 0.4× 132 0.3× 472 1.6× 172 0.7× 108 2.1k
Paresh Jobanputra United Kingdom 25 106 0.2× 339 0.7× 115 0.3× 197 0.7× 131 0.5× 54 2.6k
Monika Baier United States 34 132 0.2× 361 0.8× 119 0.3× 562 1.9× 309 1.3× 60 4.5k
Emma Hamilton Australia 19 268 0.5× 174 0.4× 47 0.1× 192 0.7× 96 0.4× 58 1.3k
Andjela Drincic United States 21 140 0.2× 215 0.4× 192 0.5× 458 1.6× 206 0.9× 56 1.9k
M. Schmidt Germany 17 139 0.2× 350 0.7× 119 0.3× 330 1.1× 87 0.4× 51 1.4k
Christina M. Dieli‐Conwright United States 26 146 0.3× 150 0.3× 369 0.9× 484 1.7× 154 0.6× 112 2.6k
Staffan Eriksson Sweden 24 168 0.3× 729 1.5× 116 0.3× 548 1.9× 226 0.9× 64 2.7k

Countries citing papers authored by Mark A. Young

Since Specialization
Citations

This map shows the geographic impact of Mark A. Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Young more than expected).

Fields of papers citing papers by Mark A. Young

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Young. The network helps show where Mark A. Young may publish in the future.

Co-authorship network of co-authors of Mark A. Young

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Young. A scholar is included among the top collaborators of Mark A. Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Young. Mark A. Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roth, Jonathan D., Sanne Skovgård Veidal, Kristoffer Rigbolt, et al.. (2019). Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH. Scientific Reports. 9(1). 9046–9046. 44 indexed citations
2.
Roth, Jonathan D., Michael Feigh, Sanne Skovgård Veidal, et al.. (2018). INT-767 improves histopathological features in a diet-inducedob/obmouse model of biopsy-confirmed non-alcoholic steatohepatitis. World Journal of Gastroenterology. 24(2). 195–210. 61 indexed citations
3.
Papazyan, Romeo, Xueqing Liu, Jingwen Liu, et al.. (2018). FXR activation by obeticholic acid or nonsteroidal agonists induces a human-like lipoprotein cholesterol change in mice with humanized chimeric liver. Journal of Lipid Research. 59(6). 982–993. 53 indexed citations
4.
Blanch, Peter, et al.. (2017). Autologous tenocyte implantation into shoulder tendon pathology in an elite swimmer. Physical Therapy in Sport. 29. 19–25. 11 indexed citations
5.
Dong, Bin, Mark A. Young, Xueqing Liu, Amar Singh, & Jingwen Liu. (2016). Regulation of lipid metabolism by obeticholic acid in hyperlipidemic hamsters. Journal of Lipid Research. 58(2). 350–363. 28 indexed citations
6.
Young, Mark A., et al.. (2016). B-Flow Imaging in Lower Limb Peripheral Arterial Disease and Bypass Graft Ultrasonography. Ultrasound in Medicine & Biology. 42(9). 2345–2351. 12 indexed citations
7.
Osborne, Hamish, Lynley Anderson, Peter Burt, Mark A. Young, & David Gerrard. (2016). Australasian College of Sports Physicians—Position Statement. Clinical Journal of Sport Medicine. 26(2). 87–95. 7 indexed citations
8.
Atanelov, Levan, Steven A. Stiens, & Mark A. Young. (2015). History of Physical Medicine and Rehabilitation and Its Ethical Dimensions. The AMA Journal of Ethic. 17(6). 568–574. 10 indexed citations
9.
Young, Mark A., et al.. (2013). Complementary and Alternative Treatments for Chronic Pelvic Pain. Current Pain and Headache Reports. 17(2). 316–316. 10 indexed citations
10.
Suci, Peter A. & Mark A. Young. (2011). Selective killing of Aggregatibacter actinomycetemcomitans by ciprofloxacin during development of a dual species biofilm with Streptococcus sanguinis. Archives of Oral Biology. 56(10). 1055–1063. 9 indexed citations
11.
Irving, Damien, Jill Cook, Mark A. Young, & Hylton B. Menz. (2008). Impact of Chronic Plantar Heel Pain on Health-Related Quality of Life. Journal of the American Podiatric Medical Association. 98(4). 283–289. 186 indexed citations
12.
Irving, Damien, Jill Cook, Mark A. Young, & Hylton B. Menz. (2007). Obesity and pronated foot type may increase the risk of chronic plantar heel pain: a matched case-control study. BMC Musculoskeletal Disorders. 8(1). 41–41. 182 indexed citations
13.
Lionetti, Vincenzo, Axel Linke, Mary H.H. Chandler, et al.. (2005). Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure. Cardiovascular Research. 66(3). 454–461. 92 indexed citations
14.
Young, Mark A., J L Cook, Craig Purdam, Z S Kiss, & H Alfredson. (2005). Eccentric decline squat protocol offers superior results at 12 months compared with traditional eccentric protocol for patellar tendinopathy in volleyball players. British Journal of Sports Medicine. 39(2). 102–105. 210 indexed citations
15.
Young, Mark A., et al.. (2003). Outcomes of a Program in Business Education for Physicians and Other Health Care Professionals. Southern Medical Journal. 96(10). 1000–1006. 6 indexed citations
16.
Kurz, Michael A., David A. Bullough, Christopher J.L. Buggé, Kevin Mullane, & Mark A. Young. (1997). Cardioprotection with a novel adenosine regulating agent mediated by intravascular adenosine. European Journal of Pharmacology. 322(2-3). 211–220. 9 indexed citations
17.
Young, Mark A., et al.. (1996). CHIEF RESIDENCY IN PM&R. American Journal of Physical Medicine & Rehabilitation. 75(4). 257–262. 20 indexed citations
18.
Young, Mark A., Dorothy E. Vatner, & Stephen F. Vatner. (1991). α- and β-Adrenergic Control of Large Coronary Arteries in Conscious Calves. Steinkopff eBooks. 85 Suppl 1. 97–109. 15 indexed citations
19.
Smith, Stephen A., et al.. (1987). Renal Effects of Nicardipine in Essential Hypertension: Differences Between Acute and Chronic Therapy. Journal of Hypertension. 5(6). 693–697. 21 indexed citations
20.
Glover, David R., et al.. (1984). Once daily indapamide in the treatment of the elderly and young hypertensive. European Journal of Clinical Pharmacology. 27(4). 397–405. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heidi Prather Breakdown of academic impact, for papers by J. W. J. Bijlsma Breakdown of academic impact, for papers by Antonino Catalano Breakdown of academic impact, for papers by Paresh Jobanputra Breakdown of academic impact, for papers by Monika Baier Breakdown of academic impact, for papers by Emma Hamilton Breakdown of academic impact, for papers by Andjela Drincic Breakdown of academic impact, for papers by M. Schmidt Breakdown of academic impact, for papers by Christina M. Dieli‐Conwright Breakdown of academic impact, for papers by Staffan Eriksson
Rankless by CCL
2026